Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 440

1.

Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity.

Sun L, Dong R, Xu X, Yang X, Peng M.

J Neuroinflammation. 2017 Jul 19;14(1):138. doi: 10.1186/s12974-017-0913-7.

2.

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.

Genaro K, Fabris D, Arantes ALF, Zuardi AW, Crippa JAS, Prado WA.

Front Pharmacol. 2017 Jun 21;8:391. doi: 10.3389/fphar.2017.00391. eCollection 2017.

3.

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1425. doi: 10.3390/ijms18071425. Review.

4.

Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years.

Maccarrone M.

Front Mol Neurosci. 2017 May 29;10:166. doi: 10.3389/fnmol.2017.00166. eCollection 2017. Review.

5.

Interactions of Cannabinoids With Biochemical Substrates.

Thomas BF.

Subst Abuse. 2017 May 29;11:1178221817711418. doi: 10.1177/1178221817711418. eCollection 2017. Review.

6.

Rice Bran and Probiotics Alter the Porcine Large Intestine and Serum Metabolomes for Protection against Human Rotavirus Diarrhea.

Nealon NJ, Yuan L, Yang X, Ryan EP.

Front Microbiol. 2017 Apr 21;8:653. doi: 10.3389/fmicb.2017.00653. eCollection 2017.

7.

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1.

Ratano P, Palmery M, Trezza V, Campolongo P.

Front Pharmacol. 2017 Apr 12;8:200. doi: 10.3389/fphar.2017.00200. eCollection 2017.

8.

Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.

Munawar N, Oriowo MA, Masocha W.

Front Pharmacol. 2017 Mar 20;8:136. doi: 10.3389/fphar.2017.00136. eCollection 2017.

9.

Endocannabinoids: A Promising Impact for Traumatic Brain Injury.

Schurman LD, Lichtman AH.

Front Pharmacol. 2017 Feb 17;8:69. doi: 10.3389/fphar.2017.00069. eCollection 2017. Review.

10.

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.

Cassano T, Calcagnini S, Pace L, De Marco F, Romano A, Gaetani S.

Front Neurosci. 2017 Feb 2;11:30. doi: 10.3389/fnins.2017.00030. eCollection 2017. Review.

11.

The endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?

Lipina C, Hundal HS.

J Mol Cell Biol. 2017 Apr 1;9(2):91-103. doi: 10.1093/jmcb/mjx008. Review.

12.

Molecular Targets of the Phytocannabinoids: A Complex Picture.

Morales P, Hurst DP, Reggio PH.

Prog Chem Org Nat Prod. 2017;103:103-131. doi: 10.1007/978-3-319-45541-9_4. Review.

13.

Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Babayeva M, Assefa H, Basu P, Chumki S, Loewy Z.

Parkinsons Dis. 2016;2016:1279042. doi: 10.1155/2016/1279042. Epub 2016 Dec 5. Review.

14.

CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma.

Ferrini ME, Hong S, Stierle A, Stierle D, Stella N, Roberts K, Jaffar Z.

Allergy. 2017 Jun;72(6):937-947. doi: 10.1111/all.13107. Epub 2017 Jan 23.

PMID:
27992060
15.

Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure.

Miller S, Leishman E, Oehler O, Daily L, Murataeva N, Wager-Miller J, Bradshaw H, Straiker A.

Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6419-6426. doi: 10.1167/iovs.16-19437.

16.

Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Gertsch J.

Br J Pharmacol. 2017 Jun;174(11):1464-1483. doi: 10.1111/bph.13676. Epub 2017 Jan 16. Review.

PMID:
27891602
17.

The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.

Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R, Maldonado RL, Cravatt BF, Lichtman AH.

Neuropharmacology. 2017 Mar 1;114:156-167. doi: 10.1016/j.neuropharm.2016.11.015. Epub 2016 Nov 25.

PMID:
27890602
18.

Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.

Nguyen T, Li JX, Thomas BF, Wiley JL, Kenakin TP, Zhang Y.

Med Res Rev. 2017 May;37(3):441-474. doi: 10.1002/med.21418. Epub 2016 Nov 23. Review.

PMID:
27879006
19.

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.

Rohleder C, Müller JK, Lange B, Leweke FM.

Front Pharmacol. 2016 Nov 8;7:422. eCollection 2016. Review.

20.

Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration.

Mendizabal-Zubiaga J, Melser S, Bénard G, Ramos A, Reguero L, Arrabal S, Elezgarai I, Gerrikagoitia I, Suarez J, Rodríguez De Fonseca F, Puente N, Marsicano G, Grandes P.

Front Physiol. 2016 Oct 25;7:476. eCollection 2016.

Supplemental Content

Support Center